CLINICAL_TRIALS
trial_result
· 2019-09-16
Clinical Trial Update: A Safety Study of LY2886721 Single Doses in Healthy Subjects [Phase 1]
Summary
Phase 1 safety study of a single dose of LY2886721 in healthy subjects completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-09-16